you missed novo or eli? >> we get asked that a lot pfizer is not in phase three with the oral compound. this is a hot area and any time you see clinical general amgen had a small number of patp patients got excited about last year it takes a long time from phase one to fda approved drug i cover astrazeneca as well. they are fully engaged in a pipeline in obesity as well. it is some time before we have more data pointss from who will be out in the commercial market. if you want to plan on obesity, novo and eli. >> emily field, thank you. >> thank you. >>> ahead on the show, the average manhattan rent just did something for the first time ever likely pricing out millions of folks along the way. our robert frank is here wh it that story coming up >>> welcome back to "worldwide exchange." time for the big money movers. app applovin citing the rollout of the advertising product as the key driver for the positive quarter. shares up 24%. shares of sonos popping after the equipment company beat the earnings and narr

there is novo nordisk. the chart paints a incredible picture and many have compared to -- the stock to the forms we have seen out of companies like apple. this is an anti-obesity drug but now we are -- it is seeing benefits for cardiology, stroke patients. that is significant because it will make it easier for the insurance companies to pay out to use the drug. novo nordisk rallying massively, the stock of 17% and the liaison up -- and lily is up. alix: the same thing he is talking about exactly the same here at my side of the pond. the stories are similar. eli lilly is at a record. the weight loss drug blue past expectations but it was writing on the coattails of others. all the weakest performers within the s&p save one are part of the regional banks from the downgraded of moody and the ones on the watchlist of a negative rating. that won't happen for about two hours is the three year option. we are seeing some buying come in. we are looking at yields down about eight basis points. tons of demand. kailey:

joining us now is novo nordisk ceo, lawyeura jorgeson. let's start with what we know right now what the white house is negotiating for some of these medications and what that means for the two insulin drugs that you have on the list. >> thank you for having me. it was announced yet that some of our insulin will be on the list of products to be negotiated we welcome support of patients. the unfortunate situation is that while we face declining internet pricing, those benefits are not always for the patients. so now we see that some of our products are part of the products to be negotiated with the government, and we'll see how that will play out. that's not perfectly clear to us yet. >> so you don't yet know exactly how that will impact the financials? >> well, the list of products shown show the cost, we give significant already to the government. which means that from a financial point of view, the value of those are actually quite modest to us, so it's not something that affects our business, because we're already rebate and significant

novo nordisk, the drug cutting risk of heart attack and stroke by 20% we'll talk to mr. irgin and echo star ceo >>> a day after s&p and nasdaq broke the four-day losing streak, stocks back in the red financials in focus among laggards after moody's talking about interest rate and asset liability risk. >> what's incredible is we just went through the quarters. with the exception of, honestly, key, the quarters were good. a lot of them had inflows. people thought there would be outflows david, when you see these kinds of downgrades, don't you see -- >> yes, yes, yes. >> good, good, good. done, done, done move on, move on, move on. >> you can't pay for this kind of analysis. >> no, you really can't. >> it's important because financials represent a huge part of the market, and if we're going to have blending, we can't have as much lending that's kind of what we're saying my problem with it is it doesn't jive with the facts. it was entirely possible, entirely possible we could have been in a situation where all these banks did poorly let's say jpmorgan, bank of america, goldm

eli lilly and novo nordisk hitting record highs lily on strong highs, novo on positive data on the weight loss drug, those helping the broader sector, the only s&p group in the green right now. it's been interesting for health care it's the third best sector over the last month, but the third worst for the year bryn, you picked health care in your stock summit as a sector pick when you hear the results today, while not involved in the individual names, does it sort of give you, i don't know, more credence, maybe to look deeper at this name going forward, as a defensive play or otherwise, based on what you heard today? >> i mean, it's very exciting with novo's announcement their weight loss drug, you know, improves cardiac events by 20% those stocks are up 15, and eli and novo up 15, 16%, which eli is 7% of xlz and i think that's pulling up the whole sector. going into the year, health care was my pick, but i did feel we were late stage cycle and that consumer, utilities, and companies like procter & gamble were just over valued. health care to me was the way to be invested what's happenin

somebody was 50 pounds more novo nordisk had early lead in this type of drug.as one that could be approved for obesity later this year, it appears to be more effective and they won the drug pipeline that appears to be more effective than that, what about the stocks, novo, lily do those stocks look attractive to you. >> i would be cautious lily is up 50%, trading for 60 times earnings and the market cap is bigger then merck and pfizer, $500 billion for lily and the trillion for the two companies. it's a lot of good news baked into the stock. jack: the could make a lot of money but it's in the price. >> it may be in the price right now. bed tech stocks have sold often obesity plays a role, what is going on. >> last month we heard into widow and bariatric surgery because people. jack: stomach stapling. >> exactly. people are interested in trying the obesity drug. recovering from bariatric surgery very difficult not saying some of the drugs are without side effects. but it's also going into other parts of the med tech industry. when you lose weight, your chances of

more on that in just a bit with the shares of almost 14% same for novo nordisk.he banks, moodies cutting the ratings of ten u.s. banks. leslie picker is here with more. these we call them the big regionals and maybe some of the trust banks. is that right? >> that's exactly right. there are 27 ratings actions in all, all along this same thing interest rates likely to remain higher for longer. amid quantitative tightening assets, loans and liabilities deposits, risks associated with monetary policy, have been pressuring profitability and regulators are layering new potential rules on mid size banks that could cause them to ultimately pull back on loan making which could, of course, affect profitability as well then there's that canary known as commercial real estate. talk about it all the time on this show. particularly office buildings and certain pockets of the country that have plum meted in value due to the prevalence of remote work. q2 earnings releases informed the ratings actions which is interesting because prior to today's move the kre was up a whopping 20

. >> i want to talk about lilly and novo nordisk., as well as mounjaro, are covered under medicare part d if they are described for diabetes management. so, what are the chances that these drugs come next? >> oh, it's a matter of time. >> just a matter of time. synthetic -- synthetic end to exclusivity for their biggest money makers right now. >> i believe so. it just -- it depends on the ramp of revenue and how significant these are for the medicare population specifically. but i would think within the next few years, for sure. there will be some impact. i think ozempic will go first. mounjaro might take a little bit longer, because the weight loss drug, if you look at wegovy and mounjaro for novo and lilly, those populations are probably not huge medicare populations. but ozempic could surely go maybe next year, the year after. >> so many questions surrounding that in terms of what the model looks like then. but with the select data on wegovy, if it has shown that it is going to be prescribed to prevent cardiac events, does that ch

. >>> shares of novo nordisk are sliding after the huge run this week they make the drug wegovy. they reported a 30% increase of sales for the first half of the year with wegovy sales jumping to $1.5 billion. they raised outlook for 2023 it sounds great. the stock is up after the late-stage trial data for wegovy, but it did not just help for weight loss, but reduced heart attack and stroke. we will have more later this hour. >>> let's talk disney. bob iger reported an operating profit revenue grew to $22.2 billion. raising prices on streaming platforms and cracking down on password sharing bob iger commented on streaming ad strength on the earnings call yesterday. >> the ad marketplace is picking up it is healthier than linear television we believe in the streaming platforms on disney plus and hulu we are trying to migrate more subs to the advertising tier. >> joining us right now is ben smith. semafor co-founder he still wish he sold buzzfeed to disney. he writes about that in his book ben, good to see you how are you? >> good. thanks for having me on. >> let's talk about the ea

edward jones >>> shares of novo nordisk are up sharply this morning.at to see you again we were just talking about the select trial yesterday on "fast money. a 20% reduction was way beyond what anybody was expecting what does it mean in terms of reimbursement in your view >> great seeing you, too, melissa. as you said, 20% is well ahead of expectations. it will open up the market to a bigger patient population over time you know, managed care and these insurance companies can kind of get around the cost of prescribing more drugs over the near term for obesity. there's now a long-term large clinical trial that proves that there's a big cardiovascular health benefit for patients staying on the drugs near term, and also over the long-term, i think the obesity category will be one we will continue to watch. insurance companies are obviously going to have to find a way to carve these drugs into their plans at an affordable price. these are the two main things we are look at this morning >> how soon do we start hearing about reimbursement, and how soon do an

tomorrow and the focus will be on weight loss products what can we expect and can new trial results from novo nordisk change the game? >>> and, a new high for uri, and tyson shareholders why the coop. the details behind all those stocks are coming up mim i'm melissa lee, this is "fast money. everyone here in-house we start with the potential warning signs of the market. major indices with solid gains the do w adding 400%. the nasdaq, not far behind but not everyone came along for the ride check out apple, pulling back more than a percent and a half today. the world's biggest tech company is now more than 9% off its all-time high hit in mid-july. that's not all microsoft managed a gain today, but down 10% from its record high last month. so, is this cause for concern or a sign that the rally has actually broadened out, that we can move beyond just these two, you know, generals, dan? >> yeah, so, when you think about the moves that the two of them have, okay, technically, they have broken the uptrend in place for most of this year. that's important in a market where people don't really care muc

a spokesperson for novo nordisk says stomach side effects are well known and mostly mild. plans to go digital by 2025. it's a calling their planned. the paperless processing initiative. >> officials say that it will cut processing times in half and speed up your refunds. there's no need to worry if you're not digitally savvy. the ira says it. you can still mail in paper returns. still ahead, an unexpected debate. the ongoing public feud between 2 powerhouses heading to the stage. why we can soon see. >> governor gavin newsom and governor ron desantis going head to head. california governor gavin newsom in florida. governor ron desantis could soon take their ongoing public feud to the debate stage. >> each now expressing interest in debating the other capitol correspondent eytan wallace shares the formal debate offer. newsom sent to desantis and what desantis is saying about >> i'm just sent us since they're claiming this freedom gospel leadership matters. they are doing it wrong here. no wonder why we've had so many people moved from san francisco to florida. they have not

the two of these guys, up 42% for lily novo, up 40% both get gold stars because both hit record highsthat craze over obesity drugs >> more later on that. >>> now to that blockbuster news from moody's, out with a big warning about capital and liquidity for larger u.s. banks. that has led to private lenders to step in to fill the void. don peebles just told us how this works >> the competitors in this process for this loan were all private credit in the past, it would have been a mixture of a national global bank, a couple regionals, and one or two private credit lenders. but we have done deals previously with private credit, but the bulk have been with global or regional banks >> my next guest provided the credit for that deal peach tree group invests in commercial real estate and have completed hundreds of transactions let's bring in ceo greg friedman thank you for being here with me >> thank you >> private credit, i wasn't even sure what it was trying to describe it felt like an area where there was a lot of pension fund money, and now people talk about it as if it's a common sense a

novo nordisk maker of ozempic, saying gastrointestinal events are well known side effects, adding theare mild to moderate and typically only occur for a short duration. eli lilly, maker of manjaro, tells abc news. we actively engage in monitoring and reporting safety information for all our medicines. meanwhile, many employers are now cutting off insurance coverage for similar weight loss drugs, which can cost more than $1,300 a month, straining employer funded health plans. as for this new lawsuit, novo nordisk said extreme gastric problems can have a variety of causes, including adding diabetes itself. >> coming up, the governors of florida and california prepare for a showdown. >> plus, a follow up on the controversy involving the zoo and whether the bears are and whether the bears are actually humans in disguise your record label is taking off. but so is your sound engineer. you need to hire. i need indeed. indeed you do. indeed instant match instantly delivers quality candidates matching your job description. visit indeed.com/hire new nature's bounty hair growth. help grow thicke

novo nordisk saying it's drugs are safe and it constantly monitors them and that it was on affair ofan, thank you very much. the u.s. for the first time in 12 years has h had its credit rating downgraded. the credit rating agency fitch has cut the u.s. froits long-standing triple-a rating to aa plus, citing growing government debt and political instability, highlighted by the january 6th attack on the capital. that triggered wall street's first day in months, with the dow dropping 1%, the s&p falling 1.4%, and the nasdaq sinking more than 2%. officials in los angeles fear a wave of evictions and a rise in the homeless population. the concern comes after the deadline for renters to pay back rent missed during the pandemic has come and gone. cbs's mark srassmann has more in depth, reporting on how l.a. is not alone with this pending crisis. >> this is a three day eviction notice. >> reporter: susie rossman's rattled by reality. the bill always comes due. how much you owe him back rent? >> $9,000. >> reporter: can you pay that back? >> as slowly, but not how they want it. so probably --

the cover of the nivea publication caused such a stir in the posts, this is the former edition of novoe vremya voice a-a , it was called that, we are approaching victory now my colleagues maybe they will find her. then we will show her to you there. in the foreground was prytula, a little behind him. yes, the president of ukraine , volodymyr zelenskyi, let me remind you for a second that the supreme commander-in-chief of the armed forces of ukraine and the president of our country are somewhere in in the third row, fifth or seventh from the left, was the commander-in-chief of the armed forces of ukraine, valery zaluzhnyi, well, none of those unknown to us, any military, well, there were various people, volunteers, certain people whose well, few people know, but in a word, vladka was a cohort of people, and he was again in the foreground serhiy prytula and the inscription we are getting closer, they are getting closer to victory, and there were a lot of different reactions to this edition, of course you know. you can think , well, the magazine is out, there is a cover, the face is distur

. >>> plus, weight loss, stock gain shares of eli lilly and novo nordisk jumping. lde they worth their weight in go don't go anywhere. "fast money" is back in two. the biggest ideas inspire new ones. 30 years ago, state street created an etf that inspired the world to invest differently. it still does. what can you do with spy? ♪ ♪ ♪( please don't go by harry casey, richard raymond finch )♪ ( ♪ ♪ ) ♪ (please don't go) ♪ ♪ (please don't go) ♪ ♪ (please don't go) ♪ ♪ (please don't go) ♪ ♪ (don't gooo) ♪ ( ♪ ♪ ) ♪ (don't go away) ♪ pre-order now and get a free storage upgrade. ♪ (please don't go) ♪ >>> welcome back to "fast money. we've got a couple of afterhours movers let's start off with rivian. shares struggling. the ev maker upping its 2023 production target. the conference call is under way right now. phil lebeau has been listening in phil, what's the latest >> melissa, they are just beginning the q&a portion. i'll be curious to see how many questions are in here that might give us some insight into why the stock is selling off it was up 80% in the last three mo

novo nordisk and eli lilly.ehealth company hims and hers is getting into the weight loss management business, but in what form? we've got the ceo next. and talk about heavyweights, you're not going to believe this. even at the height of his career, star quarterback in the nfl joe theismann never weighed more than 190 pounds. and his height? he's barely 6 feet tall. so how did joe tower over the competition, win a super bowl, get named mvp and then -- and in a way here's the real accomplishment -- create a whole new life for himself when right in the football prime of his life he suffered a horrific career-ending injury? he reveals it all in my brand new episode of my everyone talks to liz podcast. just dropped a couple of hours ago. folks, we've talked -- topped is.5 million -- 1.5 million downloads because people want to know how super successful individuals turn stumbling blocks into steppingstones so that you can earn and -- learn and do it too. joe theismann did it in not one, but two careers. and, by the wa

. >>> and novo and lilly is facing lawsuits over ozempic and mounjaro a case from a 44-year-old woman who suffered severe vomiting after taking the drug. there are other clients with the same allegations novo said it is not aware of the lawsuit, but notes that gastro issues is a known risk for people with diabetes, dom. >>> thank you. more to come here on "worldwide exchange," and the one word investors have to know today, but first, fitch makes the case in the u.s. downgrade in the exclusive interview where jamie dimon is taking it with a grain of salt. >>> and keeping a hawkish tone we look to the bank of england as it is set to release the latest policy decision. >>> and later on, robinhood not we rewarded after the quarterly trade. we have more after this break. ss both large and small, communities and the people who live and work there grow and thrive. we're proud to call these places home too. they're where we put down roots, and where together, we work to help move everyone's financial goals forward. pnc bank. what if buildings could tell you how they could be more efficient? i

were carry some traffic violations related to the car, but decided to let them off with a warrant novo. here's a reminder of our top story. emergency crews and johannesburg say they expect to find more victims in a multi story building that caught fire overnight. at least 74 people are dead and dozens more were injured in the place. right, well that you are up to date and that next is dw business, which looks at whether europe's energy supply is secure. rob watts has old news. stay tuned for thought. i'll be back again at the top of the next hour. thanks so much. take care. the come have a huge this out to the highlights you every week in your inbox. subscribe. now you become a criminal pretty client. i already told me about sugars paralyzed between your society.

still had, novo nordisk shares to a record after an obesity drug showed benefits.e will bring you that story and many more. this is bloomberg. ♪ dani: it is "bloomberg daybreak europe." i am dani burger and london. president and ceo of marigold has told bloomberg that china's economy is not going back to where it was very he spoke to us about the hortons of comfort -- comfort to his business. >> we should be 30% of our business which will be copper by the end of the decade. and it might be very much more on the bottom line because -- the bottom line of the copper price because copper is going to run out. if you believe in the forecast growth for copper, and i do. >> it feels like for the energy transition you have to have a lot of copper. in the short term, mark, it was dismal trade data out of china. trade data is getting hit hard today -- copper is getting hard today. what is your take on it now? mark: we are not going to see china go back to where it was. it is a very big component of the global economy. it is a consumer of all metals, but also, i think we got r

say a russian worship has been badly damaged in a droned attack on russia's black sea naval base and novo rusk. a video published on social media appears to show the seaborne drone moments before impact other footage shows a listing ship being towed to shore. russia says the attack was formed. police were called to new york, new york city's union square to disperse a large crowd that got out of control sizes of people flocked to the square after a popular internet streaming star per promised. a huge giveaway. police said they couldn't immediately say how many people have been injured or arrest or something. now from the world of sports of gunner stands, women's football team might not have qualified for the world cup in australia, but a team representing the nation is an exile in melbourne. dw, corresponding tom generally went to meet their goal keeper, who fled with her teammates. when the tyler bond returned to power 2 years ago to nowadays nobody is how so these are scan with but to use it goes when goalkeeper find somebody. so if the entered teammates arrived in australia, they knew n

but a lawsuit filed today against manufacturers novo nordisk and eli lilly claims othe otherwise, saying drugs can cause stomach paralysis, a 44-year-old louisiana woman who took the drugs for type 2 diabetes and weight loss. >> her problems have been so severe she has been to the emergency room multiple times, including last weekend. she is actually even thrown up so violently that she's lost teeth. >> reporter: stomach paralysis can be a side effect of diabetes, which the drugs are commonly prescribed for. ria hand who is not involved in the lawsuit has had similar issues with ozempic. >> the stomach pain was unbearable. and i couldn't keep anything down. i would drink something and within minutes, five, ten minutes i would be throwing it right up. >> reporter: more than 40% of americans are obese and demand for thehe medicationsns has soa. they aren't cheap. a one-month supply can cost more than $1,300. but now the university of texas system says it will end insurance coverage for the fda-approved weight loss drugs wegovy and saxenda in september. others are increasing the copay amoun

miss on earnings and its worse day and the stock down 19% meanwhile, on the upside, eli lilly and novo nordisk in all-time highs in today's session and fueled by demand for its diabetes drug in hopes that it will get approved from novo nordisk, and the treatment reduced and heading for its best day in two decades and by the way, we will hear from eli lilly's ceo tonight on "mad money" with jim cramer mike >> seema, thank you. >> let's get the results of our twitter question of the day or x question as we you in call it. we ask you to position your portfolio more defensively, slight majority, 51% saying yes, 49% still on offense up next, rivian results hitting the tape in just a few minutes we'll break down the key themes and metrics to watch out for, that and much more when we take you inside "the market zone. ( ♪♪ ) ( sfx: people cheering ) ( sfx: stock exchange bell ringing ) ( ♪♪ ) ( ♪♪ ) ( sfx: people celebrating ) ( ♪♪ ) ( sfx: people celebrating ) ( sfx: stock exchange bell ringing ) every business that's why comcast business ( de is launching theal. ) mobile made free event. wit

truly phenomenal we also got data from novo nordisk, the competitor with wegovy or ozempic and might be a matter of time because a huge chunk of the population has its life altered by this i think the health insurers and medicare will come around to pay for them because they are that life saving. in response the numbers and the possible action eli lille jumped nearly 15% and makes sense and have one of the best-selling drugs in history, 15% gain is too small. maybe it should have been 25%. either way this company is worth a heck of a lot more today than yesterday but didn't have this incredibly positive new information. you invent an amazing new product and sells like crazy then your stock soars. that's perfectly passable action the other side of the trade makes defense too. the medical devices saw their stocks sell off and will have less business if litlly's shot does perfectly logical that they're selling off because there's so many things that this can do right. second example, does it make sense nvidia is the number one performing stock of the year on the s&p 500? of course, it d

novo nordidisk. drivining chan.t's up with hililldale. [cheerering and apapplause] ♪ ♪♪ on y your periodod, sudddden gushes s happen. say goodbybye gush feaears! thanks too alwaysys ultra thihins... wiwith rapiddrdry technololog. thatat absorbs t two times f f. hellooooo clean anand comforta. alalways. fear no gugush. every bubusiness deserves a a great deaeal. that's whyhy comcast b busins helloo is lauaunching theherta. mobile m made free e event. with ourur businesss ininternet, nenew and exisisg cucustomers cacan geget one yearar of unlimimd momobile for f free. it's our b best internrnet. powered byby the nextt geneneration 10g0g network ad wiwith 99.9% r reliabilityt. plus one l line of freree momobile for a an entire y y. it's's the mobilile made fre evevent-happenening now. get t started fofor jujust $49.99 9 a month. plusus, ask how w to get onene line of f unlimited d mobil. comcast t business,s, poweriring possibibilities. feel thehe power ofof osteo bi-i-flex®.. taken evevery day, it's's clinicalllly sho

novo nordidisk. drivining chan. how whwhite do youou think your teethth really arare?f, stilill yellow.. whitenining toothpasaste can n only do soso much. there's s toothpastete whit, and therere's cresest 3d whitestripips white. so mucuch whiter!! crest. ♪ ♪ [cheers and applause] >> stephen: give it up for the band, everybody! right there, louis cato and "the late show" band. there you go. louis. >> louis: stephen. good to see you. >> stephen: good to see all of you. i know we've got a couple guests tonight. some of you are out on a gig. i love seeing you on the kit. >> louis: got to hold it down. >> stephen: playing the guitar with your feet. coming up in just a little while, the lovely, the talented actor james marsden is going to be out here. and taking the colbert questionert, mr. nicolas cage will be right out. folks, right now, there's one big story that we haven't talked about yet, partly because it's partly about us. for the past few weeks, the writers guild of america, which is the union representing television and film writers, has been negotiating with the

freddy: la sorpresa fue daniel novo, que no marcaban mucho en las encuestas, gracias al buen desempeÑoos ricos contra los pobres, la revancha social, y algo que en el pasado les funcionÓ, pero hoy en dÍa la realidad es otra. freddy: aunque gonzÁlez ganÓ con claridad la votaciÓn del domingo el corre ismo ya perdiÓ la segunda vuelta en un escenario parecido frente al actual presidente guillermo laso en las elecciones del 2021, ¿por quÉ si luisa gana por 10 puntos muchos consideran que novoa es el favorito? >> tal vez la gente fuera de ecuador cree que es una circunstancia muy fÁcil, pero daniel novoa tiene mÁs fÁcil endosar los votos de los demÁs candidatos, paralice mÁs complicado captar mÁs votos. freddy: al final la Última palabra la tiene como siempre los votantes. recordar que la segunda vuelta serÁ el 15 de octubre y dejan una constancia, desde el comienzo de esta cobertura especial de univisiÓn en ecuador le hemos perdido una entrevista a la candidata luisa gonzÁlez, pero no hemos recibido respuesta hasta el momento. jorge: vamos hasta guatemala donde bernardo arÉvalo obtuvo la vi

shares in novo nordisk continue to go higher, they make wegovy and ozempic and bloomberg points out thoseby many for weight loss are so successful, novo nordisk is responsible for most of the economic growth in its home country of denmark. the overall value of the company, $413 billion, is bigger than the overall gdp of denmark at $406 billion. something smells fine in the state of denmark. it's money. >>> the white house just released a list of drugs medicare will pay less for. ozempic not on it, but another diabetes drug is. ten in all. i spoke with someone in the drug industry who represents the people who invest millions in pharmaceuticals. he said drugmakers are concerned smaller profits will leave them with less money for research. >> which may mean that pharmaceutical companies choose not to be in this market or they may choose not to develop a drug for the american market. we've already seen some companies make some tough decisions because the economics under this new system make no sense. and so we face the inevitable choice of fewer medicines available in order to achieve some c

shares in novo nordisk are continuing to march higher.his is the company that makes both wegovy and ozempic. and those drugs used by many for weight loss are so successful, novo nordisk is now responsible for most of the economic growth in its home country of denmark. in fact, "the new york times" points out the overall value of the company, $413 billion, is bigger than the gdp of denmark at $406 billion. something smells fine in denmark, and it is money. >>> the white house just released a list of drugs medicare will now pay less for. ten in all. this takes effect in 2016. farxiga, eliquis, jardiance, xarelto, januvia, stelara, novolog. i spoke with somebody in the industry who represents the people who invest millions in pharmaceuticals. he says drugmakers are concerned smaller profits will leave them with less money for research. >> which may mean that pharmaceutical companies choose not to be in this market or they may choose not to develop a drug for the american market, and we've already seen some companies make some tough decisions

spokesperson for novo nordisk nordics norse disc says that the stomach side effects are well known andild. in national news, irs, they want to make it easier for you to file your taxes by embracing a digital future. well, a new plan call paperless processing will now allow taxpayers to directly submit documents and corresponding visually by 2024. so by 2025 all those paper returns and documents will be digitized. all goes well, the irs estimates 94% of taxpayers. we'll never have to send another piece of mail to the agency. it's part of a broader push to improve technology as a way of boosting customer service and winning over skeptical public. well, the irs says it's working on a plan to allow taxpayers to fall directly with the agency without having to go through a tax professional. okay. we'll ex blue users, meaning the people who pay for that blue check mark on the platform, formerly known as twitter. they now have the option of hiding the checkmark. it's a purely because some users say they are being targeted. people are making fun of them. moffat other twitter users. okay. now th

novo nordisk announced yesterday that the drug reduced the risk of heart attacks and stroke by 20%.ding cause of death. the findings are also the first to demonstrate that a weight loss drug could have additional health benefits, potentially paving the way for insurance companies to cover the expensive medication. let's bring in dr. vin gupta, pulmonologist, and msnbc medical contributor. always good to see you. so we should say, novo nordisk has not released the full clinical trial results and outside scientists have yet to review it, but if it is true, how big of a deal could this be? >> well, chris, good afternoon, this is yet another finding to your point, data is not publicly available, that should encourage us all in public health and medicine. what we have seen from this class of drugs, wegovy, ozempic, munjaro, a different but similar medication, people are shedding weight on these drugs, 20% of body weight on the highest doses of the medication, it's once a week, an injectable medication. the data released yesterday in press release form is encouraging. i'll say something w

novo nordidisk. drivining chan. the riright age fofor neutrogena® retinol?rproven retinil ththat targetsts vital l cell turnonover, evens skinin tone, and smooooths fine l lines. with v visible resesults inin just one e week. neutrorogena® retetinol fefeeling sluguggish oror weighed d down? it c could be a a sign thatt yoyour digestitive systemm isn'n't at its b best. metamumucil gummieies make it y to get t the fiber y you . promomoting yourur digestive healthth for a a better yoy. memetamucil gugummies. the easy w way to get your d daily fiber. ♪ -bararista: “enjoy” ♪ -gley: “oh, sorry y” ♪ -manisha: : “how arare you” -gley:y: “good! !” ♪ introducing togo's new frech dip sandwiwiches. featuring g fresh artitisan brd pileled high witith tender roaoast beef, smothehered with m melty provovolone cheeeese, just e enough chipipotle maya and serveded with hot t au ju for didipping. trtry the roasast beef or r pasi frenench dips totoday. only at t togo's. he s snores likeke an angngry rhino.. you've neverer heard an angry r rhino. babyby i hear onone everery nigh

a spokesperson for novo nordisk says that stomach side effects are well known and mostly mild. >> well, the irs plans to go digital by the year 2025. so in just a couple of years from now, they're calling their plan, the paperless processing initiative. officials say it'll cut processing times in half and speed up those refunds that you're waiting for. however, there's no need to worry if you're not a digitally savvy person. the irs says you can still mail in your return via paper. if you'd like. well, according to reports, sales force is now cutting more jobs following the previous layoffs that we saw earlier this year. the job cuts will primarily affect sales and customer success. team members in ireland. it's unclear if the current round of layoffs would impact workers in other countries beyond that. but it was in january as we know, the disco based software provider had announced that it would be reducing its global workforce by about 10% or roughly 88,000 employees. >> 10 21 right now and the original fills coffee location in san francisco is soon going to serve its final cup. thi

now because of a new lawsuit, the plaintiff accuses novo nordisk and eli lilly of downplaying. >> the severity of side effects to the stomach and the intestines that can happen when you take these drugs. there were symptoms that were so severe in one case that. >> a woman lost her teeth because of heavy vomiting. >> both of these drugs were developed to treat type 2 diabetes, but they have been used recently by a lot of people for weight loss. a spokesperson for novo nordisk says that stomach side effects are well known and mostly mild. >> well, the irs plans to go digital by the year 2025, they're calling the plan the paperless processing initiative. officials say the cut processing time in half and speed up. refunds. however, there's no need to worry if you are not digitally savvy. the irs says you can still mail in your paper returns. well, according to reports, sales force is cutting more jobs following previous layoffs earlier this year. the job cuts will primarily affect sales and customer success. team members in ireland. it's unclear if the current round of layoffs will impact

delivered eight missile strikes against the accumulation of enemy manpower and firepower in the areas of novo-sadovayachervonnoye rebrovo. in the area of ​​the torsky site of the silver forestry. the enemy made five attempts to regain the lost positions by the advanced units of the cent grouping, with support. artillery fire, fire damage was inflicted on the assault groups of the 63rd 42nd mechanized brigades of the armed forces. from a headache there is askofen p at an affordable price and askofen ultra with a reinforced composition to combat headaches and migraines askofen when your head hurts, it's hard not to notice the legendary alfa bank credit card with new benefits. order a credit card for a year without interest. now with cashback on all purchases and free bank cash withdrawals. now in new packaging. buy a big combo and build a collection glasses at a delicious point why credit savings cards are the most profitable in the country every month a new interest-free period of 120 days begins. make purchases. return money. so again and again free forever superstar of nine eight percent. checkout on

much of the world's insulin production comes from one of 3 companies. eli lilly saying that fee for novo, nor disk. i like to call april garcia and into an overdose. right. so if you're eating a high car meal, you need a high dose. eventually, you're applying a balancing act between it's high car and it's high dose of insulin. and sometimes you roll the dice and you, you hit it, but most of the time you're going to be off one way or the other. you know, this isn't an option on medicine, this isn't a vitamin or something that will help with allergies. this is life saving. if our children don't have insulin, they die. that's what happened to kids. before insulin came around, you did your best to limit carbohydrates, but their blood sugars were high, they wasted away and they died. when i was diagnosed at 9 years old, i remember i was about 35 pounds. if you see any of those pictures that going way back to like before, insulin, and then after insulins you have these kids that were skin and bones. that was me. what i do remember is probably every 15 to 30 minutes, i was drinking 1620 ounces

and the novo pen which is insulin. prices on insulin very important to many americans, though a lot on the list are what the industry calls small molecule drugs. simple pills made of compounds that easily enter the blood streamism spoke to an expert who represents investors in the drug industry who worries lower prices will mean smaller profits and less research into those kinds of drugs. >> there are thousands of companies, but a lot in the bay area that have devoted themselves to investing and working in the small molecule space. unfortunately, there's less incentive to work on those drugs. the one in your medicine cabinet. we have to work hard with congress to reduce that. >> if most of these common drugs that we're talking about are not as profitable, it might push drug makers to spend less on copying each other, trying to do the same drug, and do something new instead. these price reductions take effect in 2026, according to the law. >> certainly affect a lot of people's bottom line. >> thank you. >>> heads up for

center with army aviation strikes and artillery fire, two enemy attacks in the areas of settlements, novo-vodyanoyervonoye dibrova of the lugansk people's republic in during the fighting, up to thirty ukrainian servicemen were destroyed an infantry fighting vehicle and an armored personnel carrier up to 30,080 servicemen apu losses per day in the donetsk direction belogorovka klesheevka, and near berestovoye krasnohorovka and marinka, the offensive was not simply repelled our troops improved their positions . the d-20 howitzer cannon is not the newest gun, but the fighters love it for it. she even has a name for the asterisk cannon. well, also as a symbol, it never let us down, we work, 24/7 after adjusting from the air, strikes hit the target shot. 152 mm shells hit ukrainian mortar crews western artillery systems objective control captures the accuracy of hitting the map of hostilities is closely monitoring the uk has identified three areas near the ticks in kyivstar mayorovka and work on the armed forces. they are really trying to attack for the guardian calls it a war of attrition. on all three

so way, novo said lowering and there's no increased risk dash. so in the area we start is put this on this. of course, here's the city does not have enough money to conduct a more complex survey of the residents. that the villain uses a buzz that'll basically to would prove or disprove. on this, the cynthia diesel is up such as the king size zone. however, the city's health risk analysis states 90 percent of the residents study to have abnormal blood cell counts more than half reported cancer cases in their families. traces of previous chemical production are everywhere on the former grandson is awesome and this extensive area is freely accessible. funeral, a dangerous chemical and irritant was produced in this building as a result of its toxicity. this part of the factory was already closed out in 1989. the rinaldo valasics battle often feels futile. the cause of them shit, balls. yeah. as you can. so you know, now they do everything they can to make my life more difficult. i keep hearing made up stories about being a former director who'd been

danish company novo nordisk says that the drug slashed the risk of serious heart issues by 20% in a trial 17,000 overweight and obese adults with cardiovascular disease and no history of diabetes. the study could help persuade insurers to pay for the drug and costs about $1,300 a month. >>> "the hill" says an online crowdfund to assist marine veteran daniel penny with legal fees has raised nearly $3 million. the 24-year-old has pleaded not guilty to manslaughter and negligent homicide charges in the choke hold death of a man on a subway train in may. penny says that he was protecting himself and others after jordan neely threatened people and acted erraticalli. he was homeless and had a history of mental illness. penny's legal team says any left over money will be donated to mental health charities. >>> "people" magazine says thousands of mourners in sinead o'connor's hometown in ireland paid reports as the singer was laid to rest. fans lined the streets as the funeral procession passed through following a private memorial service. some sang her hit "nothing compares to you" as the hearse

part of the produced novo-yoganskoye deposit goes for processing to the plant.on from the oil , it is sent to a gas turbine power plant. it is located in the same field. its capacity is 72 mw and provides the generation of about half of the electricity consumed by the industry. the facility was built in 2008. at full load, in 2 hours , it is enough to consume about 35,000 cubic meters of gas of associated petroleum gas so that the gas turbine operates at full capacity power plants, so that associated petroleum gas is ready for use at the station, it undergoes additional purification until then. until its characteristics come close to natural gas in recent years. lukoil has built a lot of gas turbines and gas reciprocating power plants thanks to such stations in western siberia with more than 400 mw of installed capacity. that is, this brute is constantly in operation, that is , it generates energy year-round to completely reduce the need for deposits, carbon dioxide emissions on an industrial scale is a task that is put before all companies in the world among th